Wang, L., Wen, X., Luan, F., Fu, T., Gao, C., Du, H., . . . Ji, J. (2019). EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway. Cancer Manag Res.
Citação norma ChicagoWang, Lin, et al. "EIF3B Is Associated With Poor Outcomes in Gastric Cancer Patients and Promotes Cancer Progression Via the PI3K/AKT/mTOR Signaling Pathway." Cancer Manag Res 2019.
MLA CitationWang, Lin, et al. "EIF3B Is Associated With Poor Outcomes in Gastric Cancer Patients and Promotes Cancer Progression Via the PI3K/AKT/mTOR Signaling Pathway." Cancer Manag Res 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.